Genmab A/S Files 6-K, Incorporated into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: May 21, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | May 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
Related Tickers: GMAB
TL;DR
Genmab filed a 6-K, updating its S-8 filings for stock plans.
AI Summary
Genmab A/S filed a Form 6-K on May 21, 2024, to report information as a foreign private issuer. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, and 333-277273.
Why It Matters
This filing ensures that Genmab's ongoing registration statements for its equity incentive plans are kept up-to-date with current information, which is crucial for employee stock options and grants.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically pose a risk.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date is May 21, 2024.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, specifically File Nos. 333-232693, 333-253519, 333-262970, and 333-277273.
What is the principal executive office address of Genmab A/S?
The principal executive office address is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Does Genmab A/S file annual reports under Form 20-F or 40-F?
Genmab A/S files annual reports under Form 20-F, as indicated by the checked box.
Filing Stats: 220 words · 1 min read · ~1 pages · Grade level 14.4 · Accepted 2024-05-21 11:38:09
Filing Documents
- tmb-20240521x6k.htm (6-K) — 18KB
- tmb-20240521xex99d1.htm (EX-99.1) — 28KB
- tmb-20240521xex99d1001.jpg (GRAPHIC) — 5KB
- 0001558370-24-008522.txt ( ) — 54KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF MAY 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. nthony GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: May 21, 2024 EXHIBIT INDEX O Exhibit Description of Exhibit 99.1 Company Announcement Dated May 21, 2024: Genmab Completes Acquisition of ProfoundBio